ArticleFrontiers in oncology2026

Prolonged survival in a HER2 positive metastatic breast cancer patient with brain metastases treated with TDM1 after failure of next generation HER2 targeted therapies: case report.

Benedetta Trevisan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.